NEW YORK (GenomeWeb) – Finnish in vitro molecular diagnostics manufacturer Mobidiag has completed a €4.0 million ($4.3 million) funding round, the firm announced today. The funding was supported by Finnish investment service company Kansalaisrahoitus Oy.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.